Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
about
Traumatic Axonal Injury: Mechanisms and Translational OpportunitiesTraumatic brain injury, neuroinflammation, and post-traumatic headachesPhysiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryRole of Microvascular Disruption in Brain Damage from Traumatic Brain InjuryAdhesion molecules in CNS disorders: biomarker and therapeutic targetsIdentification of injury specific proteins in a cell culture model of traumatic brain injuryCortical hypoexcitation defines neuronal responses in the immediate aftermath of traumatic brain injuryInflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokinesChronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury modelSpecific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and strokeBlast Overpressure Waves Induce Transient Anxiety and Regional Changes in Cerebral Glucose Metabolism and Delayed Hyperarousal in RatsSevere traumatic head injury affects systemic cytokine expressionRecombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.Neuroprotective effects of progesterone in traumatic brain injury: blunted in vivo neutrophil activation at the blood-brain barrier.C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammationSystemic inflammation and cerebral palsy risk in extremely preterm infants.Principal component analysis of the cytokine and chemokine response to human traumatic brain injury.Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?(R)-(+)-α-lipoic acid protected NG108-15 cells against H₂O₂-induced cell death through PI3K-Akt/GSK-3β pathway and suppression of NF-κβ-cytokines.Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regenerationTraumatic Brain Injury Increases Cortical Glutamate Network Activity by Compromising GABAergic ControlOsthole confers neuroprotection against cortical stab wound injury and attenuates secondary brain injuryA pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agentCirculating Inflammatory-Associated Proteins in the First Month of Life and Cognitive Impairment at Age 10 Years in Children Born Extremely Preterm.Molecular and cellular mechanisms of pulmonary fibrosis.Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury BiomarkerAcetate reduces microglia inflammatory signaling in vitroInflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injuryModulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes.Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-κB signaling pathway in experimental traumatic brain injury.Traumatic axonal injury in the mouse is accompanied by a dynamic inflammatory response, astroglial reactivity and complex behavioral changesCerebral microdialysis in clinical studies of drugs: pharmacokinetic applicationsEndocannabinoids in cerebrovascular regulation.Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury.Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury.Cytokine gene polymorphisms and outcome after traumatic brain injury
P2860
Q26753059-9FF393D0-3A3A-4F85-9568-4EEF6F5CC34FQ26830912-06B8D7DD-C3FA-44C1-B77D-A8615B17B151Q26861408-5AF3E81A-6EE0-4A58-AD13-484BD0259EE8Q27009187-648B5D1B-9E89-4ADB-89DE-645C654007B9Q27015967-58085FDC-496F-4384-BA11-0B1E24564A15Q27315716-309C5EFB-AC54-4E1C-BA60-0F9B1340EB28Q27320749-D354D3D1-ACBD-4C6A-B209-8AA108D17D7AQ28088301-D88ED83F-5858-4479-9041-6F3DF5665CC4Q28302146-A4C092CA-1ACF-47AD-8DEC-D6662F006BD1Q28535065-39A722BE-2FCB-4D0D-B23B-0B684DD68748Q30407825-DAFB3A81-311C-4745-8EF6-CA59288C09F3Q30421596-E3518EFB-1D3C-4926-9AFB-0E7603F627F4Q33581165-2090270B-D4BB-4ADF-A2BB-324A9FADB118Q33742612-5ABD1261-0012-4EF0-906B-52F63C0D2B59Q33747387-57C4FC41-3FE7-489F-8BF7-82A1F9BB7D30Q34108791-20FA2FFD-3941-4C72-8002-838AE58B45D2Q34154658-A7FC5088-6EAA-4C2F-8B09-349165FCD24FQ34207382-93E7CC85-0733-4E51-813C-6A6895615447Q34321617-80E7F674-4DE7-4F80-8A9C-37113A020EDFQ34570859-708B9825-2196-4958-9C73-E3F480D6B5AFQ35094550-4484D995-A467-400A-8701-FB562E67F2BDQ35357443-B074371F-DD85-401C-994E-544FCEE5986FQ35600150-D598D120-F7D8-416A-90DA-E2BDB81A085BQ35826125-9EB98592-9FD9-4B27-969A-0D3989945EEEQ36024014-0E46E762-4E12-4811-B294-96E0B39FF8BAQ36090064-4182D200-3E0D-4A77-A68D-B4B7F96C3B52Q36176573-97A42897-97EA-462A-B054-AF1EF8D511D8Q36237168-512083EC-FDAB-4908-B352-0869D8DF2500Q36294820-A3495739-D5E4-432B-8987-8018587ED15FQ36319571-C5731D7A-4E22-4D45-8656-CCA13F0B98ABQ36583786-C62966F7-5232-4277-B2F2-71A9A2C8B9AAQ36654889-2B8F5675-CDA1-4000-82DD-6155A25DCF50Q36684264-0811D825-1B66-4D30-A796-F54AFF3F8796Q36835134-A9003E9A-695C-4EE4-AE84-4C9F1AB4D9C3Q36872983-89863010-69DC-4FFA-88D9-BFF3B9AD1E2CQ36895795-589E2408-761A-4388-B01E-8E2B8856592CQ37073380-3C1C12B8-4184-4763-B0A6-B50FA524A026Q37152382-E991ED87-FAB7-4DA9-B169-063D98E3C69AQ37212082-A80D3112-63BC-4110-A7B8-5E4447440088Q37229166-26779E4D-30CA-471B-883C-AAF7FCE2CD1D
P2860
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
@en
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
@nl
type
label
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
@en
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
@nl
prefLabel
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
@en
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
@nl
P50
P921
P1476
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury
@en
P2093
Mathew R Guilfoyle
Peter J Hutchinson
P304
P356
10.1016/J.PNEUROBIO.2011.09.003
P577
2011-09-16T00:00:00Z